Description
Leukaemic stem cells in AML: where are we now? An update on recent findings and detection
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: Leukaemic stem cells in AML: where are we now? An update on recent findings and detection
€3.03
Reviews
There are no reviews yet.